Methods of detecting prostate stem cell antigen in cancer
US6960443B2 · kind B2 · utility
13Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2002 |
| Grant date | Nov 1, 2005 |
| Priority date | — |
| Expiry date | Aug 20, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.